Copper handling by astrocytes: Insights into neurodegenerative diseases

International Journal of Developmental Neuroscience

Volumn 29, Issue 8, 2011, Pages 811-818

  Tiffany Castiglioni, Evelyn ^a   Hong, Sandra ^b   Qian, Yongchang ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b EXPONENT INC   (United States)

Author keywords

Alzheimer's disease; Astrocyte; Copper homeostasis; Glucose regulated protein 78; Parkinson's disease; Protein chaperone

Indexed keywords

COPPER; LEAD; TRACE ELEMENT;

ALZHEIMER DISEASE; ASTROCYTE; BIOACCUMULATION; CELL CULTURE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; COPPER METABOLISM; DEGENERATIVE DISEASE; GENETIC MODEL; HUMAN; MENKES SYNDROME; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; COPPER; DISEASE MODELS, ANIMAL; HUMANS; NEURODEGENERATIVE DISEASES;

MURINAE;

EID: 80455176849     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.09.004     Document Type: Review

References (140)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Acarin L., Carrasco J., Gonzalez B., Hidalgo J., Castellano B. Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury. J. Neuropathol. Exp. Neurol. 1999, 58:389-397.
3. Arciello M., Rotilio G., Rossi L. Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage. Biochem. Biophys. Res. Commun. 2005, 327:454-459.
4. Arredondo M., Munoz P., Mura C.V., Nunez M.T. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 2003, 284:C1525-C1530.
5. Attwell D., Laughlin S.B. An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 2001, 21:1133-1145.
6. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., Bush A.I. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 2000, 75:1219-1233.
7. Banci L., Bertini I., Ciofi-Baffoni S., Hadjiloi T., Martinelli M., Palumaa P. Mitochondrial copper(I) transfer from Cox17 to Sco1 is coupled to electron transfer. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6803-6808.
8. Bannon D.I., Abounader R., Lees P.S., Bressler J.P. Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells. Am. J. Physiol. Cell Physiol. 2003, 284:C44-C50.
9. Barnes N., Tsivkovskii R., Tsivkovskaia N., Lutsenko S. The copper-transporting ATPases, menkes and wilson disease proteins, have distinct roles in adult and developing cerebellum. J. Biol. Chem. 2005, 280:9640-9645.
10. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000, 2:326-332.
11. Boll M.C., Alcaraz-Zubeldia M., Montes S., Rios C. Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem. Res. 2008, 33:1717-1723.
12. Brown D.R. Prion protein peptides: optimal toxicity and peptide blockade of toxicity. Mol. Cell Neurosci. 2000, 15:66-78.
13. Brown D.R. Role of the prion protein in copper turnover in astrocytes. Neurobiol. Dis. 2004, 15:534-543.
14. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., Connor J.R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 2001, 66:1198-1207.
15. Bush A.I. Copper, zinc, and the metallobiology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2003, 17:147-150.
16. Cancilla P.A., Barlow R.M. Structural changes of central nervous system in swayback (enzootic ataxia) of lambs 3. Electron microscopy of the cerebral lesions. Acta Neuropathol. 1966, 6:260-265.
17. Carrasco J., Giralt M., Penkowa M., Stalder A.K., Campbell I.L., Hidalgo J. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha. Exp. Neurol. 2000, 163:46-54.
18. Chelly J., Tumer Z., Tonnesen T., Petterson A., Ishikawa-Brush Y., Tommerup N., Horn N., Monaco A.P. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet. 1993, 3:14-19.
19. Chen S.H., Lin J.K., Liu S.H., Liang Y.C., Lin-Shiau S.Y. Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol. Sci. 2008, 102:138-149.
20. Chinta S.J., Kumar M.J., Hsu M., Rajagopalan S., Kaur D., Rane A., Nicholls D.G., Choi J., Andersen J.K. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J. Neurosci. 2007, 27:13997-14006.
21. Choi B.-S., Zheng W. Copper transort to the brain by blood-brain barrier and blood-CSF barrier. Brain Res. 2009, 1248:14-21.
22. Chung R.S., Hidalgo J., West A.K. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J. Neurochem. 2008, 104:14-20.
23. Chung R.S., Penkowa M., Dittmann J., et al. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem. 2008, 283:15349-15358.
24. Crichton R.R., Dexter D.T., Ward R.J. Metal based neurodegenerative diseases-from molecular mechanisms to therapeutic strategies. Coord. Chem. Rev. 2008, 252:1189-1199.
25. Culotta V.C., Klomp L.W., Strain J., Casareno R.L., Krems B., Gitlin J.D. The copper chaperone for superoxide dismutase. J. Biol. Chem. 1997, 272:23469-23472.
26. Danks D.M. Disorder of copper transport. Metabolic Basis of Inherited Disease 1989, 1411-1431. McGraw-Hill, New York. A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
27. Danks D.M., Campbell P.E., Stevens B.J., Mayne V., Cartwright E. Menkes's kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics 1972, 50:188-201.
28. Danks D.M., Cartwright E., Stevens B.J., Townley R.R. Menkes' kinky hair disease: further definition of the defect in copper transport. Science 1973, 179:1140-1142.
29. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 1996, 143:137-142.
30. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 1989, 52:1830-1836.
31. Dierick H.A., Adam A.N., Escara-Wilke J.F., Glover T.W. Immunocytochemical localization of the Menkes copper transport protein (ATP7A) to the trans-Golgi network. Hum. Mol. Genet. 1997, 6:409-416.
32. Dringen R., Bishop G.M., Koeppe M., Dang T.N., Robinson S.R. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res. 2007, 32:1884-1890.
33. El-Youssef M. Wilson disease. Mayo Clin. Proc. 2003, 78:1126-1136.
34. Fell B.F., Mills C.F., Boyne R. Cytochrome oxidase deficiency in the motor neurones of copper-deficient lambs: a histochemical study. Res. Vet. Sci. 1965, 6:170-177.
35. Ferreira A.M., Ciriolo M.R., Marcocci L., Rotilio G. Copper(I) transfer into metallothionein mediated by glutathione. Biochem. J. 1993, 292(Pt 3):673-676.
36. Field L.S., Luk E., Culotta V.C. Copper chaperones: personal escorts for metal ions. J. Bioenerg. Biomembr. 2002, 34:373-379.
37. Gaasch J.A., Lockman P.R., Geldenhuys W.J., Allen D.D., Van der Schyf C.J. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem. Res. 2007, 32:1196-1208.
38. Garrick M.D., Dolan K.G., Horbinski C., et al. DMT1: a mammalian transporter for multiple metals. Biometals 2003, 16:41-54.
39. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ. 2007, 14:1324-1335.
40. Giaume C., Maravall M., Welker E., Bonvento G. The barrel cortex as a model to study dynamic neuroglial interaction. Neuroscientist 2009, 15:351-366.
41. Glerum D.M., Shtanko A., Tzagoloff A. Characterization of COX17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase. J. Biol. Chem. 1996, 271:14504-14509.
42. Glerum D.M., Shtanko A., Tzagoloff A. SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae. J. Biol. Chem. 1996, 271:20531-20535.
43. Goldstein I.M., Kaplan H.B., Edelson H.S., Weissmann G. Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals. Ann. N.Y. Acad. Sci. 1982, 389:368-379.
44. Gong Y.H., Elliott J.L. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Exp. Neurol. 2000, 162:27-36.
45. Goodyer I.D., Jones E.E., Monaco A.P., Francis M.J. Characterization of the Menkes protein copper-binding domains and their role in copper-induced protein relocalization. Hum. Mol. Genet. 1999, 8:1473-1478.
46. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
47. Hamza I., Faisst A., Prohaska J., Chen J., Gruss P., Gitlin J.D. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6848-6852.
48. Hamza I., Prohaska J., Gitlin J.D. Essential role for Atox1 in the copper-mediated intracellular trafficking of the Menkes ATPase. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1215-1220.
49. Hartter D.E., Barnea A. Brain tissue accumulates 67copper by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process. J. Biol. Chem. 1988, 263:799-805.
50. Haywood S., Paris J., Ryvar R., Botteron C. Brain copper elevation and neurological changes in north ronaldsay sheep: a model for neurodegenerative disease?. J. Comp. Pathol. 2008, 139:252-255.
51. Hendershot L., Wei J., Gaut J., Melnick J., Aviel S., Argon Y. Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5269-5274.
52. Hidalgo J., Aschner M., Zatta P., Vasak M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res. Bull. 2001, 55:133-145.
53. Hiser L., Di Valentin M., Hamer A.G., Hosler J.P. Cox11p is required for stable formation of the Cu(B) and magnesium centers of cytochrome c oxidase. J. Biol. Chem. 2000, 275:619-623.
54. Holm I.E. Neo-Timm and selenium stainable glial cells of the rat telencephalon. Histochemistry 1989, 91:133-141.
55. Hozumi I., Hasegawa T., Honda A., et al. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 2011, 303:95-99.
56. Jaiser S.R., Winston G.P. Copper deficiency myelopathy. J. Neurol. 2010, 257:869-881.
57. Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 2003, 278:27144-27148.
58. Kitazawa M., Cheng D., Laferla F.M. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J. Neurochem. 2009, 108:1550-1560.
59. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 1999, 39:267-294.
60. Klomp L.W., Lin S.J., Yuan D.S., Klausner R.D., Culotta V.C., Gitlin J.D. Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J. Biol. Chem. 1997, 272:9221-9226.
61. Kodama H. Recent developments in Menkes disease. J. Inherit. Metab. Dis. 1993, 16:791-799.
62. Kodama H., Meguro Y., Abe T., Rayner M.H., Suzuki K.T., Kobayashi S., Nishimura M. Genetic expression of Menkes disease in cultured astrocytes of the macular mouse. J. Inherit. Metab. Dis. 1991, 14:896-901.
63. Kralovicova S., Fontaine S.N., Alderton A., Alderman J., Ragnarsdottir K.V., Collins S.J., Brown D.R. The effects of prion protein expression on metal metabolism. Mol. Cell Neurosci. 2009, 41:135-147.
64. Kuhlow C.J., Krady J.K., Basu A., Levison S.W. Astrocytic ceruloplasmin expression, which is induced by IL-1beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor. Glia 2003, 44:76-84.
65. La Fontaine S.L., Firth S.D., Camakaris J., et al. Correction of the copper transport defect of Menkes patient fibroblasts by expression of the Menkes and Wilson ATPases. J. Biol. Chem. 1998, 273:31375-31380.
66. Laitusis A.L., Brostrom M.A., Brostrom C.O. The dynamic role of GRP78/BiP in the coordination of mRNA translation with protein processing. J. Biol. Chem. 1999, 274:486-493.
67. Leary S.C., Sasarman F., Nishimura T., Shoubridge E.A. Human SCO2 is required for the synthesis of CO II and as a thiol-disulphide oxidoreductase for SCO1. Hum. Mol. Genet. 2009, 18:2230-2240.
68. Lee J., Pena M.M., Nose Y., Thiele D.J. Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem. 2002, 277:4380-4387.
69. Lee S.J., Park M.H., Kim H.J., Koh J.Y. Metallothionein-3 regulates lysosomal function in cultured astrocytes under both normal and oxidative conditions. Glia 2010, 58:1186-1196.
70. Lindenau J., Noack H., Possel H., Asayama K., Wolf G. Cellular distribution of superoxide dismutases in the rat CNS. Glia 2000, 29:25-34.
71. Lloyd D.R., Phillips D.H. Oxidative DNA damage mediated by copper(II), iron(II) and nickel(II) fenton reactions: evidence for site-specific mechanisms in the formation of double-strand breaks, 8-hydroxydeoxyguanosine and putative intrastrand cross-links. Mutat. Res. 1999, 424:23-36.
72. Loeffler D.A., LeWitt P.A., Juneau P.L., et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 1996, 738:265-274.
73. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
74. Lutsenko S., Bhattacharjee A., Hubbard A.L. Copper handling machinery of the brain. Metallomics 2010, 2:596-608.
75. Maragakis N.J., Rothstein J.D. Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006, 2:679-689.
76. Masters B.A., Quaife C.J., Erickson J.C., Kelly E.J., Froelick G.J., Zambrowicz B.P., Brinster R.L., Palmiter R.D. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 1994, 14:5844-5857.
77. Maurer I., Zierz S., Moller H.J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 2000, 21:455-462.
78. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 1988, 263:17205-17208.
79. Menkes J.H., Alter M., Steigleder G.K., Weakley D.R., Sung J.H. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 1962, 29:764-779.
80. Mercer J.F., Livingston J., Hall B., et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 1993, 3:20-25.
81. Mills C.F., Williams R.B. Copper concentration and cytochrome-oxidase and ribonuclease activities in the brains of copper-deficient lambs. Biochem. J. 1962, 85:629-632.
82. Monty J.F., Llanos R.M., Mercer J.F., Kramer D.R. Copper exposure induces trafficking of the Menkes protein in intestinal epithelium of ATP7A transgenic mice. J. Nutr. 2005, 135:2762-2766.
83. Murata Y., Kodama H., Mori Y., Kobayashi M., Abe T. Mottled gene expression and copper distribution in the macular mouse, an animal model for Menkes disease. J. Inherit. Metab. Dis. 1998, 21:199-202.
84. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003, 26:523-530.
85. Orth M., Schapira A.H. Mitochondria and degenerative disorders. Am. J. Med. Genet. 2001, 106:27-36.
86. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 2002, 22:6578-6586.
87. Pedersen M.O., Larsen A., Stoltenberg M., Penkowa M. Cell death in the injured brain: roles of metallothioneins. Prog. Histochem. Cytochem. 2009, 44:1-27.
88. Penkowa M., Nielsen H., Hidalgo J., Bernth N., Moos T. Distribution of metallothionein I+II and vesicular zinc in the developing central nervous system: correlative study in the rat. J. Comp. Neurol. 1999, 412:303-318.
89. Petris M.J., Camakaris J., Greenough M., LaFontaine S., Mercer J.F. A C-terminal di-leucine is required for localization of the Menkes protein in the trans-Golgi network. Hum. Mol. Genet. 1998, 7:2063-2071.
90. Petris M.J., Mercer J.F., Culvenor J.G., Lockhart P., Gleeson P.A., Camakaris J. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. Embo J. 1996, 15:6084-6095.
91. Petris M.J., Smith K., Lee J., Thiele D.J. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J. Biol. Chem. 2003, 278:9639-9646.
92. Pope S.A, Milton R., Heales S.J. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem. Res. 2008, 33:1410-1418.
93. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13363-13383.
94. Qi M., Byers P.H. Constitutive skipping of alternatively spliced exon 10 in the ATP7A gene abolishes Golgi localization of the menkes protein and produces the occipital horn syndrome. Hum. Mol. Genet. 1998, 7:465-469.
95. Qian Y.C., Harris E.D., Zheng Y., Tiffany-Castiglioni E. Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells. Toxicol. Appl. Pharmacol. 2000, 163:260-266.
96. Qian Y.C., Tiffany-Castiglioni E. Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem. Res. 2003, 28:153-162.
97. Qian Y.C., Tiffany-Castiglioni E., Harris E.D. Copper transport and kinetics in cultured C6 rat glioma cells. Am. J. Physiol. 1995, 269:C892-C898.
98. Qian Y.C., Tiffany-Castiglioni E., Harris E.D. A Menkes P-type ATPase involved in copper homeostasis in the central nervous system of the rat. Brain Res. Mol. Brain Res. 1997, 48:60-66.
99. Qian Y.C., Tiffany-Castiglioni E., Welsh J., Harris E.D. Copper efflux from murine microvascular cells requires expression of the menkes disease Cu-ATPase. J. Nutr. 1998, 128:1276-1282.
100. Qian Y.C., Zheng Y., Abraham L., Ramos K.S., Tiffany-Castiglioni E. Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells. Brain Res. Mol. Brain Res. 2005, 134:323-332.
101. Qian Y.C., Zheng Y., Ramos K.S., Tiffany-Castiglioni E. GRP78 compartmentalized redistribution in Pb-treated glia: role of GRP78 in lead-induced oxidative stress. Neurotoxicology 2005, 26:267-275.
102. Qian Y.C., Zheng Y., Ramos K.S., Tiffany-Castiglioni E. The involvement of copper transporter in lead-induced oxidative stress in astroglia. Neurochem. Res. 2005, 30:429-438.
103. Rao R.V., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 2004, 11:372-380.
104. Reddy P.V., Rao K.V., Norenberg M.D. The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab. Invest. 2008, 88:816-830.
105. Roberts H.E., Williams B.M., Harvard A. Cerebral oedema in lambs associated with hypocuprosis, and its relationship to swayback. I. Field, clinical, gross anatomical and biochemical observations. J. Comp. Pathol. 1966, 76:279-283.
106. Sales N., Rodolfo K., Hassig R., Faucheux B., Di Giamberardino L., Moya K.L. Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci. 1998, 10:2464-2471.
107. Scheiber I.F., Mercer J.F., Dringen R. Copper accumulation by cultured astrocytes. Neurochem. Int. 2010, 56:451-460.
108. Scheiber I.F., Schmidt M.M., Dringen R. Zinc prevents the copper-induced damage of cultured astrocytes. Neurochem. Int. 2010, 57:314-322.
109. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
110. Shin B.K., Wang H., Yim A.M., et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 2003, 278:7607-7616.
111. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 1992, 142:128-130.
112. Squitti R., Salustri C. Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease. Curr. Alzheimer Res. 2009, 6:476-487.
113. Stahl N., Borchelt D.R., Hsiao K., Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987, 51:229-240.
114. Strozyk D., Launer L.J., Adlard P.A., et al. Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol. Aging 2009, 30:1069-1077.
115. Sturtz L.A., Diekert K., Jensen L.T., Lill R., Culotta V.C. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone,CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem. 2001, 276:38084-38089.
116. Szerdahelyi P., Kasa P. Histochemical demonstration of copper in normal rat brain and spinal cord. Evidence of localization in glial cells. Histochemistry 1986, 85:341-347.
117. Texel S.J., Xu X., Harris Z.L. Ceruloplasmin in neurodegenerative diseases. Biochem. Soc. Trans. 2008, 36:1277-1281.
118. Tiffany-Castiglioni E., Legare M.E., Schneider L.A., Hanneman W.H., Zenger E., Hong S.J. Astroglia and lead neurotoxicity. The Role of Glia in Neurotoxicity 1996, 175-200. CRC Press, Boca Raton. M. Aschner, H.K. Kimelberg (Eds.).
119. Tiffany-Castiglioni E., Qian Y.C. Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 2001, 22:577-592.
120. Tiffany-Castiglioni E., Qian Y.C. Chapter 26 astroglia and lead neurotoxicity. The Role of Glia in Neurotoxicity 2005, 417-437. CRC Press, Boca Raton. M. Aschner, L.G. Costa (Eds.).
121. Vega C., Martiel J.L., Drouhault D., Burckhart M.F., Coles J.A. Uptake of locally applied deoxyglucose, glucose and lactate by axons and Schwann cells of rat vagus nerve. J. Physiol. 2003, 546:551-564.
122. Vaguera-Orte J., Cervos-Navarro J., Martin-Giron F., Becerra-Ratia J. Fine Structure of the Perivascular-limiting Membrane 1981, Raven Press, New York.
123. Verkhratsky A., Olabarria M., Noristani H.N., Yeh C.Y., Rodriguez J.J. Astrocytes in Alzheimer's disease. Neurotherapeutics 2010, 7:399-412.
124. Voskoboinik I., Strausak D., Greenough M., Brooks H., Petris M., Smith S., Mercer J.F., Camakaris J. Functional analysis of the N-terminal CXXC metal-binding motifs in the human menkes copper-transporting P-type ATPase expressed in cultured mammalian cells. J. Biol. Chem. 1999, 274:22008-22012.
125. Vulpe C., Levinson B., Whitney S., Packman S., Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 1993, 3:7-13.
126. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 1999, 6:221-230.
127. Watanabe S., Nagano S., Duce J., et al. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2007, 42:1534-1542.
128. Watts J.C., Balachandran A., Westaway D. The expanding universe of prion diseases. PLoS Pathog. 2006, 2:e26.
129. West A.K., Hidalgo J., Eddins D., Levin E.D., Aschner M. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 2008, 29:489-503.
130. Westergard L., Christensen H.M., Harris D.A. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim. Biophys. Acta 2007, 1772:629-644.
131. Williams J.C., Sue C., Banting G.S., Yang H., Glerum D.M., Hendrickson W.A., Schon E.A. Crystal structure of human SCO1: implications for redox signaling by a mitochondrial cytochrome c oxidase " assembly" protein. J. Biol. Chem. 2005, 280:15202-15211.
132. Williams K., Wilson M.A., Bressler J. Regulation and developmental expression of the divalent metal-ion transporter in the rat brain. Cell. Mol. Biol. (Noisy-le-grand) 2000, 46:563-571.
133. Wong P.C., Waggoner D., Subramaniam J.R., Tessarollo L., Bartnikas T.B., Culotta V.C., Price D.L., Rothstein J., Gitlin J.D. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:2886-2891.
134. Xiao G., Chung T.F., Pyun H.Y., Fine R.E., Johnson R.J. KDEL proteins are found on the surface of NG108-15 cells. Brain Res. Mol. Brain Res. 1999, 72:121-128.
135. Yamaguchi Y., Heiny M.E., Suzuki M., Gitlin J.D. Biochemical characterization and intracellular localization of the Menkes disease protein. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:14030-14035.
136. Yoshiba-Suzuki S., Sagara J.I., Bannai S., Makino N. The dynamics of cysteine, glutathione, and their disulfides in astrocyte culture medium. J. Biochem. 2011.
137. Zhang Y., Liu R., Ni M., Gill P., Lee A.S. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J. Biol. Chem. 2010, 285:15065-15075.
138. Zheng W., Xin N., Chi Z.H., Zhao B.L., Zhang J., Li J.Y., Wang Z.Y. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. FASEB J. 2009, 23:4207-4217.
139. Zheng Z., White C., Lee J., Peterson T.S., Bush A.I., Sun G.Y., Weisman G.A., Petris M.J. Altered microglial copper homeostasis in a mouse model of Alzheimer's disease. J. Neurochem. 2010, 114:1630-1638.
140. Zhou B., Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7481-7486.